Yano Masato, Terada Kazutoyo, Mori Masataka
Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Kumamoto 860-8556, Japan.
J Biol Chem. 2004 Mar 12;279(11):10808-13. doi: 10.1074/jbc.M311710200. Epub 2003 Dec 29.
Mitochondrial preproteins are synthesized in the cytosol with N-terminal signal sequences (presequences) or internal targeting signals. Generally, preproteins with presequences are initially recognized by Tom20 (translocase of the outer membrane) and, subsequently, by Tom22, whereas hydrophobic preproteins with internal targeting signals are first recognized by Tom70. Recent studies suggest that Tom70 associates with molecular chaperones, thereby maintaining their substrate preproteins in an import-competent state. However, such a function has not been reported for other Tom component(s). Here, we investigated a role for Tom20 in preventing substrate preproteins from aggregating. In vitro binding assays showed that Tom20 binds to guanidinium chloride unfolded substrate proteins regardless of the presence or absence of presequences. This suggests that Tom20 functions as a receptor not only for presequences but also for mature portions exposed in unfolded preproteins. Aggregation suppression assays on citrate synthase showed that the cytosolic domain of Tom20 has a chaperone-like activity to prevent this protein from aggregating. This activity was inhibited by a presequence peptide, suggesting that the binding site of Tom20 for presequence is identical or close to the active site for the chaperone-like activity. The cytosolic domain of Tom22 also showed a similar activity for citrate synthase, whereas Tom70 did not. These results suggest that the cytosolic domains of Tom20 and Tom22 function to maintain their substrate preproteins unfolded and prevent them from aggregating on the mitochondrial surface.
线粒体前体蛋白在细胞质中合成,带有N端信号序列(前导序列)或内部靶向信号。一般来说,带有前导序列的前体蛋白首先被外膜转位酶Tom20识别,随后被Tom22识别,而带有内部靶向信号的疏水前体蛋白首先被Tom70识别。最近的研究表明,Tom70与分子伴侣结合,从而使它们的底物前体蛋白保持在可导入的状态。然而,尚未有关于其他Tom组分具有这种功能的报道。在这里,我们研究了Tom20在防止底物前体蛋白聚集方面的作用。体外结合试验表明,无论是否存在前导序列,Tom20都能与氯化胍展开的底物蛋白结合。这表明Tom20不仅作为前导序列的受体,而且作为未折叠前体蛋白中暴露的成熟部分的受体发挥作用。对柠檬酸合酶的聚集抑制试验表明,Tom20的胞质结构域具有类似伴侣蛋白的活性,可防止该蛋白聚集。这种活性被前导序列肽抑制,这表明Tom20与前导序列的结合位点与类似伴侣蛋白活性的活性位点相同或接近。Tom22的胞质结构域对柠檬酸合酶也表现出类似的活性,而Tom70则没有。这些结果表明,Tom20和Tom22的胞质结构域的功能是维持其底物前体蛋白处于未折叠状态,并防止它们在线粒体表面聚集。